ArticleLeukemia2015
PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.
A A Mian et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papertrialcites it